Olema Pharmaceuticals (OLMA)
(Delayed Data from NSDQ)
$12.30 USD
-0.20 (-1.60%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $12.31 +0.01 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OLMA 12.30 -0.20(-1.60%)
Will OLMA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OLMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OLMA
Olema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why
Olema Pharmaceuticals, Inc. (OLMA) Is a Great Choice for 'Trend' Investors, Here's Why
OLMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Olema Pharmaceuticals, Inc. (OLMA) Could Rally 76.47%: Here's is How to Trade
Here's Why Momentum in Olema Pharmaceuticals, Inc. (OLMA) Should Keep going
Does Olema Pharmaceuticals, Inc. (OLMA) Have the Potential to Rally 80.29% as Wall Street Analysts Expect?
Other News for OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Pharmaceuticals: Still Merits A Small Holding
3 Best Stocks to Buy Now, 6/5/2024, According to Top Analysts
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Climbs on Promising Pipeline
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)